Last year the official completion of the human genome sequence was announced, capping years of hard work. Now that the flashbulbs have dimmed, scientists are taking a hard look at the results. Benefits of the sequence were prophesied to include 'magic bullet' therapeutics, individualized medicine, tools physicians can use, and ensure that these tools are readily available. Although one graduate student can now make huge strides with access to the Internet and basic molecular biology equipment, true success may demand nothing short of entirely new methods of clinical study and reorganization of existing academic structures.
